	Prof. Budhi Singh Yadav
	Designation : Professor
	Department : RADIOTHERAPY and ONCOLOGY
	yadav.budhisingh@pgimer.edu.in

:: Contact Details

Phone No.

7087008103

Ext No.

6103

:: Educational Qualification

Graduation

MBBS from IGMC Shimla in year 2000

Post Graduation

MD from PGIMER Chandigarh in year 2004

:: Area of Interest

Area Of Interest

1. Breast cancer

2. Lymphoma

3. Stereotactic RadioSurgery(SRS) & Radiotherapy

4. Deep Inspiration Breadth Hold

5. Total Body Irradiation

6. Intensity Modulated Radiotherapy

7. Image Guided Radiotherapy

8. Brachytherapy

9. Chemoradiation

10. Chemotherapy in solid tumors

11. Targeted Therapy

:: Research & Projects

Extramural Projects

1. A phase III randomized study comparing two adjuvant hypofractionated radiation schedules in patients with breast cancer.

2. Post-mastectomy radiation therapy in high risk, node negative patients of breast cancer(PMRT-NNBC).

3. A Randomized, Multiple-dose, Multicenter, Comparative Parallel study to evaluate the Efficacy, Safety and Pharmacokinetic Characteristics of Intravenous Infusion of Trastuzumab (Hetero) and Reference Medicinal Product (HERCEPTIN Trastuzumab, Genentech,Inc.) in combination with standard chemotherapy in patients of HER2-positive Metastatic breast Cancer(TRUMAB Study).

4. CR201-18 Coordinating a phase III, Multicenter, Double-Blind, Randomized, Parallel-Group, Active controlled, Two part, Global study to evaluate the Pharmacokinetics, Efficacy, Safety of BP02 {Trastuzumab} in comparison with Hereceptin - EU in patients with HER2- Positive Early Breast Cancer and HER2- Positive Metastatic Breast Cancer Study.

Research In
Progress

1. Impact of obesity on the efficacy of endocrine therapy with aromatase inhibitors in postmenopausal patients with early breast cancer.

2. Evaluation of two boost radiation schedules in post lumpectomy early stage carcinoma breast.

3. Evaluation of two versus three weeks adjuvant chest wall and locoregional radiotherapy in postmastectomy breast cancer.

4. A phase III randomized study comparing two adjuvant hypofractionated radiation schedules in patients with breast cancer.

5. Post-mastectomy radiation therapy in high risk, node negative patients of breast cancer (PMRT-NNBC)

6. A phase II study of simultaneous integrated boost with volumetric arc radiotherapy after breast conservative surgery in patients with breast cancer

7. A Randomized, Multiple-dose, Multicenter, Comparative Parallel study to evaluate the Efficacy, Safety and Pharmacokinetic Characteristics of Intravenous Infusion of Trastuzumab (Hetero) and Reference Medicinal Product (HERCEPTIN Trastuzumab, Genentech,Inc.) in combination with standard chemotherapy in patients of HER2-positive Metastatic breast Cancer(TRUMAB Study).

8. CR201-18 Coordinating a phase III, Multicenter, Double-Blind, Randomized, Parallel-Group, Active controlled, Two part, Global study to evaluate the Pharmacokinetics, Efficacy, Safety of BP02 {Trastuzumab} in comparison with Hereceptin - EU in patients with HER2- Positive Early Breast Cancer and HER2- Positive Metastatic Breast Cancer Study.

9. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): A non-inferiority, open-label, phase III randomized trial.

Area Of
Specialization

Radiation Oncology

Awards & Honours

1. Silver Medal MD, Radiation Oncology
2. AROI abroad fellowship 2011
3. Best Paper in YROC 2013
4. ESTRO Technology TransferGrant ESTRO Technology Transfer Grant for the year 2017 to learn advancedradiotherapy technique(DIBH) in lymphoma at Copenhagen University Hospital, Rigshospitalet, Copenhagen,Denmark
5. AROI Fellowship 2018 for Stereotactic Radio Surgery from Gustave Roussy, Paris, France

Member Of Professional
Bodies

1. Life member of AROI (Association Of Radiation Oncologists Of India)

2. Life member of NZAROI(North Zone Association of Radiation Oncologists)

3. Breast Cancer Foundation of India

4. Indian College of Radiation Oncologists (ICRO)

5. ESMO

:: Publications(In Vancouver Style)

A. Publications

1. Role of chemoradiation in locally advanced nasopharygealcarcinoma. Ghoshal S, Sharma SC, Rai B, YadavBS. JCRO 2004;4(1):29-31

2. Subdural hematoma secondary to carcinoma of the uterine cervix. Yadav BS, Patel FD and NijhawanR. Clin Oncol. 2005; 18:89-90.

3. Radiotherapy versus weekly comcomitant cisplatin in locallyadvanced non-small cell lung cancer- a pilot study. Yadav BS, Ghoshal S, Sharma SC, Behera D, Vikas Kapoor. BullPGI 2005; 39:75-80.

4. Quality of life in non-small cell lung cancer. Yadav BS, Ghoshal S, Sharma SC,Behera D.Radiat Oncol 2005;5(1):2-6

5. Primarylocalized high-grade lymphoma of the lacrimal gland. Yadav BS, GJ Sastri, Nalini G, Gunaseelan K, Sharma SC. Asian J Opthalmol.2007;9:32-5.

6. Treatment outcome in patients with salivary glandtumors.H. N.Lee, Yadav BS, S. Ghoshal: The Internet Journal of Head and Neck Surgery.2007. Volume 1 Number 1.

7. Non-Hodgkins lymphoma secondary to Hodgkins lymphoma. Yadav BS, Sharma SC. Radiat Oncol.2006; 6:81-84.

8. Paraneoplastic leukocytoclastic vasculitis in chronic lymphoidleukemia. Yadav BS, SharmaSC, Kapoor RK. J Cancer Res Ther. 2006; 2:206-208.

9. Tamoxifen rechallenge in postmenopausal women with recurrent ormetastatic breast cancer. Yadav BS,Sharma SC, Kapoor V and Ghoshal S. BullPGI.2006; 40:57-60.

10. Urachalcarcinoma - A rare malignancy. YadavBS, Ghoshal S and Sharma SC. RadiatOncol.2007; 7:43-45.

11. Results of letrozole in postmenopausal women aftertamoxifen treatment for advanced breast cancer. YadavBS, Sharma SC, Patel FD, Ghoshal S, Kapoor V. JCRT 2007;3:71-74.

12. Patternsof relapse in LABC treated with neoadjuvant chemotherapy followed by surgeryand radiotherapy. Yadav BS, SharmaSC, Singh R, Singh G. J C R T 2007;3:75-80

13. Treatmentof carcinoma of unknown primary. YadavBS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R Indian J PalliCare 2007;13:3-7.

14. Radiationschedules for palliation in carcinoma oesophagus. Yadav BS, Kapoor R, Sharma SC, R Kochar, Patel FD. JKScience 2007;9(3):127-131

15. Outcome following radicalcystectomy and bladder preservation therapy in patients with invasive carcinomaof the urinary bladder. Yadav BS,Ghoshal S, Sharma SC. Indian J Urol 2008;24(1):48-53

16. PostmastectomyRadiation and Survival in Patients with Breast Cancer. Yadav BS, Sharma SC, Singh R, Singh G, Kumar V. J C R T 2008;3(4):218-224

17. Second Primary in theContralateral Breast after Treatment of Breast Cancer. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R. R Radiother Oncol.2008;86:171-76.

18. Non-Breast SecondMalignancies after Treatment of Primary Breast Cancer. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R.Int J Radiat Oncol Biol Phys 2009;73:1489-92

19. Fungatingscrotal mass - A rare clinical presentation of testicular tumor. Yadav BS, Ghoshal S. Indian J Urology. 2008;24(3):406-407

20. Orbital Lymphoma: Role of radiation. Yadav BS, Sharma SC. Ind J Opthal, 2009;57:91-97

21. Accelerated Partial BreastIrradiation. Yadav BS. RadiotherOncol.2009; 90:161

22. Thyroid cancer as secondprimary malignancy in breast cancer patients. Yadav BS, Sharma SC Int J RadiatOncolBiol Phys 2009;73:1604

23. Primary sinonasal malignantmelanoma: A clinico-pathological and prognostic study. Kumar S, Gupta AK, Yadav B S, SGhoshal. Ear Nose Throat J 2009;88(12):1269-1272.

24. Therapeutic benefit ofradiotherapy after surgery in patients with T1-T2 breast tumor. Yadav BS, Sharma SC, Patel FD, Bose SM,Ghoshal S, Kapoor RK. JRP 2010; 9(1):33-40.

25. Pattern of care andsurvival in older patients with breast cancer. Yadav BS, Sharma SC, Gupta M, Patel FD, Mushraf M, Khan N, GhoshalS, Kapoor RK. JRP Volume 9 Issue 2, June 2010

26. Interfractional vaginalcuff movement. Yadav BS. Int JRadiat Oncol Biol Phys 2013; 85(1):12-13.

27. Orbital Lymphoma ALiterature Review. Yadav BS, SharmaSC. Ind J Opthal, 2009; 57:91-97

28. Osteogenic sarcoma assecond primary in contralateral breast. YadavBS, Bansal A, Sharma SC. Seminars in Oncology, Vol 40, No 2, April 2013, pp 135-144

29. Preoperative vs.Postoperative radiochemotherapy in patients with N2 squamous cell carcinoma ofthe oral cavity: In regard to Kreppel et al. Divya Khosla Yadav BS. OralOncol 2013; 49(1):e1.

30. Pediatric Astroblastoma: A Rare Case with a Review of theLiterature. Khosla D., Yadav B.S., Kumar R., Agrawal P., Kakkar N., Patel F.D., Sharma S.C. Pediatr Neurosurg 2012;48:122125

31. Significance of serumVascular Endothelial Growth Factor and Cancer Antigen 15.3 in patients withtriple negative breast cancer. Priyanka Chanana, Awadesh K Pandey, Yadav BS,et al. JRP2014;13:60-67

32. 60-year-old Indian malewith altered sensorium and extensive lymphoma of the scalp. Yadav BS, Bansal A, Sharma SC, Malhotra P, Ghosh N,Holdhoff M, Shustov A, Chamberlain M,Newton H, Kumethkar P, Raizer JN, GlassJ, and Morris GJ. Seminars in Oncology, 2013; 40,(3):9-e21

33. PrimaryNon Hodgkins lymphoma of the ovary.Yadav BS, George P, Sharma SC; McClennan E, BS; Martino MA, et al.Seminars in Oncology, Vol 41, No3, June 2014, pp e19-e30

34. Myofibroblastoma of thelarynx: a rare entity. Divya Khosla, Yadav BS, SushmitaGhoshal, Kim,Roshan Verma. JCRT 2013;9(2 ):284-286

35. Cancer lung presenting withchoroidal metastasis as initial presentation. Tapesh Bhattacharya, RakeshKapoor, Amit Bahl A, Yadav BS, Kusum Joshi, S Rane, Sharma SC. JCRT 2013;9:504-506

36. Post-mastectomy radiationbeyond chest wall in patients with N1 breast cancer is there a benefit?Yadav BS, Philip George, Anshuma Bansal, SC Sharma. JCRT 2014; 10 (2):279-83.

37. Gynaecological cancer as asecond malignancy in patients with breast cancer. Yadav B.S. Int J Gyn Cancer2013;23(1):38

38. Systemic treatmentstrategies in triple negative breast cancer. Yadav BS, Chanana P, Sharma SC, Jhamb S. WJCO 2014; 5(2):125-133.

39. SynchronousPrimary Carcinoma of Breast and Ovary versus Ovarian Metastases. Yadav BS, SharmaSC, Robin TP, Sams S, Elias AD, et al. Seminars in Oncology2015;42(2):e13-e24

40. Outcome following postmastectomyinternal mammary node radiation in patients with breast cancer- A long termfollow up study. Yadav BS, SharmaSC, Ghoshal S, Kapoor RK and Kumar N. JRP 2015; 14, 385-393

41. Biomarkersin triple negative breast cancer: A review. Yadav BS, Chanana P, Jhamb S. World J Clin Oncol 2015December 10; 6(6): 252-263

42. Metastasisto the cervix uteri fifteen years after treatment of lobular carcinoma of thebreast. Yadav BS, Jhonson NB, MorrisGJ. Seminars in Oncology 2015; 42, (4) :e81-e94

43. Hopein Palliative Care: Cultural implications. Yadav BS, Jhamb S. J Palliative Care2015:31(3):189-92.

44. Air in unusual locationafter contrast enhanced computerized tomography. LungIndia 2015;32( 6):644-45 GorsiU, Sodhi KS, Yadav BS, Khandelwal N

45. A Young Female WithMetastatic Nongestational Choriocarcinoma. YadavBS, Rai B, Suri V, Mukherjee KK, Bal A, Morgan, R, Shonka NA, Lele S,Morris GJ. Seminars in Oncology 2015;42,(6):e109-e115

46. Outcomewith combined modality treatment (CMT) in patients with Hodgkins lymphoma. YadavBS, Sharma SC, Prakash G, Malhotra P, Varma SC. Annals of Oncology 26(Supplement 9): ix85ix92, 2015

47. Metastatic behavior ofsubtypes in locally advanced breast Carcinoma. Nagpal P, Shanker A, YadavBS, Ghoshal S, Singh R, Dahiya D. Annals of Oncology; 26 (Supplement 9):ix16ix33, 2015

48. Can we apply theguidelines derived from western database to other ethnic groups? A Gail Modelbased evaluation of geo-ethnic variations in breast cancer. Thakur P, MiriyalaR, Yadav BS, Ghoshal S. CoBRA 2015

49. Hypofractionatedradiotherapy in breast cancer: What we have achieved? Bhattacharya T, MahajanR, Ghoshal S, Yadav BS and Rai B. J Cancer Res Ther.2015 Apr-Jun;11(2):259-63

50. Malebreast cancer-outcome with adjuvant treatment. B Yadav, S Sharma, R Singh, S Ghoshal

EJC 2016; 57: S97-S97

51. A phase II study of 2-weeks of adjuvant wholebreast/chest wall and/or regional nodal radiotherapy in patients with breastcancer. Budhi Singh Yadav. JCRT2015;11(1):S18-19 abstract 216

52. Assessment of dose to the left anteriordescending coronary artery in patients with left breast cancer. D. K. Das, B. S. Yadav, N. Kumar, M Singhal, N. R.Singh. JCRT 2015;11(1):S18 abstract 169

53. Breast cancer in young women- aninstitutional study from India. B. S.Yadav. The Breast 2016; 29S1, S20 PO65

54. Lower radiotherapydose in patients with Hodgkins lymphoma- is it comparable to the past standard?B.S. Yadav, S.C.Sharma¹, N.Kumar and S.Ghoshal. Ann Oncol (2016) 27 (suppl 9): doi:10.1093/annonc/mdw586.024355P

55. Outcome and prognostic factors indiffuse large B-cell lymphoma. R. Mahajan, B.S. Yadav, S. Kumar, A.Gupta, S. Ghoshal, S.C. Sharma, N.Kumar, R. Kapoor. Ann Oncol (2016) 27 (suppl 9): doi:10.1093/annonc/mdw586.022 353P

56. Gynaecological cancer as asecond malignancy in patients with breast cancer. Yadav B.S. Int J Gyn Cancer2017;27:1298-1304

57. Impact of changing trends of treatment onoutcome of cerebral gliosarcoma: A tertiary care centre experience. Narendra Kumar, Tapesh Bhattacharyya, Karan Chanchalani, Praveen Shalunke, B D Radotra,and Budhi Singh Yadav. South Asian J Cancer. 2015 Jan-Mar; 4(1): 1517.

58. Impact of acutehematological toxicity on treatment interruptions during cranio-spinalirradiation in medulloblastoma: a tertiary care institute experience Journal of Neuro-Oncology 2017

59. Hypofractionated radiotherapy in breast cancer a large institutionaldata set from India. The Breast 2017

60. Demographic Trends in Patients with Breast Cancer and its Management overa Decade. B.S. Yadav, D. Das, P.George, B. Yadav, S. Ghosal, R. Kapoor, N. Kumar, S.C. Sharma ClinicalOncology Volume 29, Issue 3, March2017, Page e72-83

61. Risk Factors for Breast Cancer How Much Weightage for Weight? B.S. Yadav, S.C.Sharma, A. Bansal, P. Thakur, B. Yadav, P. Bhusan, S. Ghoshal, R. Kapoor, N.Kumar. Clinical Oncology Volume 29, Issue 3, March2017, Page e75

62. Outcome and prognostic factors indiffuse large B-cell lymphoma (DLBCL): An institutional experience of atertiary cancer care centre from India. R. Mahajan, B.S. Yadav, S.Kumar, A. Gupta, S. Ghoshal, S.C. Sharma, N. Kumar, R. Kapoor. Int J Cancer Epidem and Res 2017;1:6-10

63. Primary bone lymphoma:An experience of a regional cancer centre from India. Rohit Mahajan, Budhi SinghYadav, SC Sharma. 2017 Annals of Oncology

64. Impactof acute hematological toxicity on treatment interruptions during cranio-spinalirradiation in medulloblastoma: a tertiary care institute experience.Narendra Kumar, Raviteja Miriyala, PragyatThakur, Renu Madan, Pravin Salunke, BudhiYadav, Ankita Gupta. Journal of Neuro-Oncology 2017; 134:309-315.

65. Hypofractionated radiotherapy in breastcancer- A large institutional data set from India. Yadav BS, Sharma SC, Ghoshal S, Singh R, Kumar N. The Breast 2017;S0960-9776(17)30255-2

66. A phase IIstudy of 2-weeks of adjuvant whole breast/chest wall and/or regional nodal radiotherapy inpatients with breast cancer. Yadav BS,Sharma SC. Int J Radiat Oncol Biol Phys 2018;100(4):871-884 doi.org/10.1016/j.ijrobp.2017.12.015

67. Workflow management inradiation oncology: the impact on a high volume department.RMiriyala, P Thakur, AO Singh, A Gupta, BSYadav, N Kumar, R Rattan, ... British Journal of Healthcare Management 2018;24 (6), 302-307

68. Postmastectomyhypofractionated radiotherapy in Stage II and III breast cancer. B. Yadav,S. Sharma, R. Singh, S. Ghoshal. EJC 2018; 92(3):S61

69. InReply to Juretic and Suton. Budhi S Yadav. Int J Radiation Oncol Biol Phys, 2018 Vol. 101, No. 5, pp. 1271e1275.

70. Primary bone lymphoma: An Experience of a regional cancer centre. R.Mahajan, B.S. Yadav, S.C. Shama, S, Ghoshal, R. Kapoor, N. Kumar. Annalsof Oncol 2017; 28(10):x94-x99.10.1093

71. Clinical behaviour of metastatic triple negativebreast carcinoma: an institutional review. Abhash Shankar, Puneet Nagpal, BudhiSingh Yadav, Divya Dahiya, Rajinder Singh and Sushmita Ghoshal. Int.J. Adv. Res. 5(6), 2301-2307

72. Metastatic behaviour of subtypes in locally advancedcarcinoma breast.Nagpal P, Shankar A, Yadav B.S,Singh R., D. Divya, Ghoshal S. Int. J. Adv. Res. 5(7), 2549-2553

73. Localised carcinoma prostate: Intensity modulatedradiotherapy (IMRT) followed by stereotactic body radiotherapy (SBRT) boost: Afeasibility study for acute toxicity GLDeepthi, N Kumar, S Kumar, BS Yadav, PK Gupta Annalsof Oncology 2018;29:ix72

74. Is fusion of a baseline PET really necessary in radiationtreatment planning of early stage lymphomas? Or will a baseline CT suffices? MCMuddabhaktuni, BS Yadav, N Kumar, GPrakash, BR Mittal, S Goshal. Annals of Oncology 2018; 29:ix91

75. Comparisonof outcome in young and very young women with breast cancer. BS Yadav,SC Sharma. The Breast 2018; 41(1):S14PO59.

76. Abstract P3-12-13: Comparisonof accelerated partial breast irradiation (APBI) with whole breast irradiation(WBI) using 3D conformal external beam radiation therapy (3D CRT) BS Yadav, S L, SC Sharma, R Singh and D Dahiya.Cancer Res February 15 2019 79 (4Supplement) P3-12-13-P3-12-13; DOI:10.1158/1538-7445.SABCS18-P3-12-13

77. Is there a need of radiation boost afterhypofractionated radiotherapy in breast cancer (BC) patients post breastconservation surgery (BCS)? BudhiS Yadav, SC Sharma, ⃰DDahiya, ⃰R Singh. The Breast 2019(March)

78. Does local treatment affect outcome inpatients with metastatic breast cancer? Budhi Singh Yadav,RubuSunku, RajinderSingh November 2019 TheBreast 48:S59 DOI: 10.1016/S0960-9776(19)30708-8.

79. PrimaryCentral Nervous System Lymphoma: An Experience of a Regional Cancer Center fromIndia. Budhi Singh Yadav, RohitMahajan, Suresh Chander Sharma , Ankita Gupta, Shikhar Kumar. J Radiat CancerRes 2019;10:104-7 DOI: 10.4103/jrcr.jrcr_15_19

80. Management of primaryneuroendocrine tumour of the breast. Dahiya D, Yadav B S, Kaman L, Vaiphei K. The Sri Lanka Journal of Surgery2019; 37(3): 1- 3

81. Late-termeffects in the arm and shoulder with hypofractionated regional nodalirradiation in patients with breast cancer. B.S. Yadav, A. Bansal, G. Philip. Annals of Oncology (2019) 30 (suppl_3):iii39-iii44. 10.1093/annonc/mdz098

82. Three-FractionAccelerated Partial Breast Irradiation Delivered With BrachytherapyApplicators: First Results From the TRIUMPH-T Trial In Regard to Khan et al. Budhi Singh Yadav, Ankita Gupta. Int JRadiat Oncol Biol Physics 2019; 104(3):697

83. Late-term effects of hypofractionated chest wall andregional nodal radiotherapy with two-dimensional technique in patients withbreast cancer. Budhi Singh Yadav, Anshuma Bansal,Philip George Kuttikat, Deepak Das, Ankita Gupta, Divya Dahiya. Radiat Oncol J [Epub ahead of print] pISSN 2234-1900 · eISSN2234-3156https://doi.org/10.3857/roj.2020.00129

84. ClinicalOutcomes and Prognostic Factors in Gastric Carcinoma Patients with CurativeSurgery Followed by Adjuvant Treatment: Real-World Scenario. Rakesh Kapoor,Chinna Babu Dracham, Srinivasa G Y, Divya Khosla, Treshita Dey, Arun Elangovan,Renu Madan, Budhi Singh Yadav,Narendra Kumar. Journal of Gastrointestinal Cancer https://doi.org/10.1007/s12029-020-00440-w

85. Three-FractionAccelerated Partial Breast Irradiation Delivered With BrachytherapyApplicators: First Results From the TRIUMPH-T Trial In Regard to Khan et al. Budhi Singh Yadav, Ankita Gupta. Int J Radiat Oncol Biol Physics2019; 104(3):697

86. Phase II randomized trial of shortcourse hypofractionated radiotherapy with or without temozolomide in elderlypatients with Glioblastoma. Neuro-Oncology 2019

87. Characteristics of malignant mediastinaltumours presenting in tertiary care center in India and the problems theoncologists have faced over time. Rajit Rattan, Budhi Singh Yadav, Rakesh Kapoor,Pragyat Thakur. Chest 26, 36.6

88. IDDF2019-ABS-0331 Intraluminalbrachytherapy (ILBT) boost following concurrent chemoradiation in patients ofinoperable oesophageal cancer a single institute experience. Gut 68(Suppl 1):A120.2-A120 DOI: 10.1136/gutjnl-2019-IDDFAbstracts.235

89. Impact of the modifiedbleomycin, etoposide and cisplatinum chemotherapy regimen on the outcome oftesticular germ cell tumor: a tertiary care institute experience. International SurgeryJournal 2019; 6 (9): 3305-3310

90. Hurdles in radiationplanning for glioblastoma: Can delayed‐contrast enhancedcomputed tomography be a potential solution? Asia-Pacific Journal ofClinical Oncology 2019;15(5):E103-108

91. Impact of volume ofirradiation on survival and quality of life in glioblastoma: a prospective,phase 2, randomized comparison of RTOG and MDACC protocols. Neuro-Oncology Practice 2019;7 (1):86-93

92. Comparison of toxicity and cosmetic outcomes after accelerated partial breast irradiation(APBI) or whole breast irradiation (WBI) using 3D conformal external beamradiation therapy (3D CRT) BS Yadav, Sofia L, SC Sharma, R Singh and D Dahiya.Advancesin Radiation Oncology 2020;5 :171-179

93. LINAC-based stereotactic radiosurgery/radiotherapy for brainmetastases in patients with breast cancer.Ankita Gupta, Budhi Singh Yadav,Nagarjun Ballari, Namrata Das and Ngangom Robert. JRP 2020.

94. Clinicopathologicalfeatures of primary central nervous system diffuse large B cell lymphoma: Experiencefrom a Tertiary Center in North India. Bishan Dass Radotra, Mayur Parkhi,Debajyoti Chatterjee, Budhi Singh Yadav,Nagarjun Rao Ballari, Gaurav Prakash, Sunil Kumar Gupta. Surgical Neurology International. 2020;11(424)

95. Health Problems and their Home-Based Management Among Breast CancerSurvivors, Attending Radiotherapy OPD, PGIMER, Chandigarh. Davinder, Himani1,Meghna, Simranjeet Kaur, Priya, Monika Dutta, Maninderdeep Kaur, Budhi SYadav. RRJoOH (2020) 1-10 ©STM Journals 2020.

96. Mitigatingthe impact of COVID-19 on oncology services in low- and middle-incomecountries: a pragmatic approach. Divyesh kumar, Budhi S Yadav BJHCM, 2020 https://doi.org/10.12968/bjhc.2020.0130

97. Mobile health (mhealth) to improve quality of life inbreast cancer survivors: study protocol for randomized controlled trial. MKaur, Budhi S Yadav, Divya Dahiya et al. EJC,2020:138(1)S91 https://doi.org/10.1016/S0959-8049(20)30778-4

98. Combined modality treatment: Outcome in patients with Hodgkin's lymphoma.iBudhi Singh Yadav, Suresh C Sharma, Pankaj Malhotra, Gaurav Prakash. JCRT2020; 16(1):1-6.

99. Comparison of two radiation boost schedules inpostlumpectomy patients with breast cancer. Budhi Singh Yadav, Suresh C Sharma, Gurpreet Singh, Divya Dahiya. JCRT 2020;16(6):1344-49

100. Clinical Outcomes and Prognostic Factors inGastric Carcinoma Patients with Curative Surgery Followed by AdjuvantTreatment: Real-World Scenario. Rakesh Kapoor, Chinna Babu Dracham, Srinivasa GY, Divya Khosla, Treshita Dey, Arun Elangovan, Renu Madan, Budhi Singh Yadav, Narendra Kumar. J of Gastro Cancer https://doi.org/10.1007/s12029-020-00440-w

101. Primary mediastinal germ cell tumors:Survival outcomes and prognostic factors - 10 years experience from a tertiarycare institute. Narendra Kumar RenuMadanChinna Babu DrachamVigneshwaranChandranArun ElangovanDivyaKhosla,BudhiSingh Yadav. Rare Tumors. 2020 Nov 18;12:2036361320972220. doi:10.1177/2036361320972220.

102. Clinical Outcomes with 2-Weeks of AdjuvantWhole Breast/ Chest Wall and/or Regional Nodal Radiotherapy in Patients withBreast Cancer B.S. Yadav and D.Dahiya. Int J Radiat Oncol Biol Physc 2020;108(3):e29

103. Breast cancer hypofractionated radiotherapyin 2-weeks with 2D technique: 5-year clinical outcomes of a phase 2 trial. Budhi Singh Yadav, Divya Dahiya, AnkitaGupta, Diksha Rana, Ngangom Robert, Manorma Sharma, Bharatbhushan Rao. RPORDOI: 10.5603/RPOR.a2021.0054

104. Does local treatment affect outcome in patients with metastatic breastcancer? Budhi Singh Yadav,Rubu Sunku, R Singh. The Breast 2019; 48, S59

105. Effect of prophylactic Granulocyte-Colony Stimulating factor (G-CSF) onacute hematological toxicity in medulloblastoma patients during CraniospinalIrradiation (CSI). Clinical Neurology andNeurosurgery 2020

106. Dosimetric comparisonof supine versus prone radiotherapy techniques in patients with breast cancer. BS Yadav, D Dhingra, N Thakur, SGhoshal, R Sharma. Journal of Radiation Oncology, 2020

107. Malebreast cancer-outcome with adjuvant treatment. B Yadav, S Sharma, R Singh, D Dahiya, SGhoshal. J Can Res Ther 2020;16:1287-93.

108. Associationof body mass index with tumor characteristics, menopausal status and hormone receptorstatus in breast cancer patients: An observational study. DDahiya, M Kaur, BS Yadav, A Kumar.European Journal of Surgical Oncology 47 (2), e46-e47

109. Comparisonof treatment seeking behavior, screening services carcinoma breast, carcinomacervix participants attending Radiotherapy OPD PGIMER, Chandigarh. Ms. BhartiDevi, Ms. V. V. Lakshmi, Ms. Maninderdeep Kaur, Dr. B. S. Yadav. Indian J of Oncol Nursing 2020